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ABSTRACT
miRNAs are small noncoding RNAs that regulate
gene expression. We have used stable isotope
labeling by amino acids in cell culture (SILAC) to
investigate the effect of miRNA-1 on the HeLa cell
proteome. Expression of 12 out of 504 investigated
proteins was repressed by miRNA-1 transfection.
This repressed set of genes significantly overlaps
with miRNA-1 regulated genes that have been iden-
tified with DNA array technology and are predicted
by computational methods. Moreover, we find that
the 30-untranslated region for the repressed set
are enriched in miRNA-1 complementary sites. Our
findings demonstrate that SILAC can be used for
miRNA target identification and that one highly
expressed miRNA can regulate the levels of many
different proteins.
INTRODUCTION
MicroRNAs (miRNAs) arise from  21 bp RNA duplexes that
are generated by the processing of  70 bp hairpin precursors
by the RNAse III enzyme Dicer (1). One of the duplex
strands is incorporated into the RISC complex and mediates
speciﬁc binding to mRNAs with complementary sequence
(1). If the miRNA has a perfect match to the target mRNA,
RISC induces cleavage of the mRNA (1). Otherwise, if the
miRNA is partially complementary to the target mRNA
initiation of translation is inhibited (1,2). Moreover, trans-
lational repression is associated with relocalisation of the
repressed mRNA to P-bodies (3,4), which may induce decap-
ping dependent degradation of the mRNA (5).
Computational studies based on conservation of miRNA
complementary sequences in the 30-untranslated regions
(30-UTRs) of mRNAs (6–8) as well as experimental studies
(9) have shown that the 50 end of the miRNA (also called
the seed) is important for recognition of target sequences.
These studies also estimate that between 10 and 30% of all
human protein coding genes are regulated by miRNAs and
that each miRNA has many conserved targets (6–8).
DNA microarrays have previously been used for miRNA
target identiﬁcation. After miR-1 duplex transfection into
HeLa cells the level of 96 mRNAs were found to be signiﬁ-
cantly reduced after both 12 and 24 h (10). Interestingly, the
30-UTR of these mRNAs were enriched for miR-1 com-
plementary sequences, indicating that the regulation occurs
via the 30-UTR. The mechanism responsible for regulation
on the mRNA level remains unclear, but may be a secondary
effect of translational repression, relocalisation to P-bodies
and decapping (5).
The primary regulatory effect of miRNAs is believed
to occur at the translational level, but compared to mRNA
proﬁling techniques changes in protein levels are difﬁcult to
assess in a high through-put fashion. We have used one of the
best available quantitative proteomics method to investigate
the effect of a miRNA on protein levels. Using this method
we ﬁnd that expression of 12 out of 504 investigated proteins
was repressed by miRNA-1 transfection. This repressed set of
genes signiﬁcantly overlaps with miR-1 regulated genes that
have been identiﬁed with DNA array technology and are
predicted by computational methods. Moreover, we ﬁnd that




HeLa cells (ACTT# CCL-2) were cultured for 9 days in
DMEM (Invitrogen) without lysine and arginine supple-
mented with dialysed fetal calf serum and isotopically labeled
Arginine (
13C6-
15N4-Arg) and Lysine (
13C6-
15N2-Lys) or
normal Arginine and Lysine. Three 15 cm dishes of  40%
conﬂuent labeled HeLa cells were transfected with Oligo-
fectamine transfection reagent (Invitrogen) and a miR-1
duplex (50-UGGAAUGUAAAGAAGUAUGUAA-30,5 0-AC-
AUACUUCUUUACAUUCAAUA-30) (Ambion, annealed
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doi:10.1093/nar/gkl590and HPLC puriﬁed custom siRNA), whereas the control cells
were transfected with oligofectamine only. Oligofectamine
was used according to the recommendations of the manufac-
turer, except that DMEM without methionine, lysine and
arginine were used for dilution instead of Opti-MEM. The
transfection volume was 20 ml and the ﬁnal concentration
of miR-1 duplex in the transfected dishes was 100 nM.
22 h post transfection the cells were trypsinised and equal
numbers of the miR-1 and control transfected cells were
mixed, spun down and resuspended in hypertonic buffer
[10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM
DTT and Complete protease inhibitor (Roche)]. The cells
were allowed to swell 5 min on ice and homogenized with
12 upward strokes in a Dounce homogenizer. The nuclei
were pelleted by centrifugation 5 min at 218 g. The super-
natant (cytoplasmic fraction) were removed and stored at
 20 C and the nuclear pellet were resuspended in 3 ml of
0.25 M sucrose containing 10 mM MgCl2 and layered on
the top of a 3 ml 0.35 M sucrose cushion containing
0.5 mM MgCl2. After centrifugation (1430 g,5 min) the super-
natant was removed and the nuclear pellet resuspended in
0.5 ml of sucrose solution and stored at  20 C. The nuclear
and cytoplasmic factions were fractionated on a 4–10%
NuPage (Invitrogen) SDS-gel that were stained with Novex
colloidal Coomassie (Invitrogen). The lanes were divided
into 10 gel pieces that were in gel reduced and alkylated
and digested with trypsin over night. The resulting peptide
mixtures were puriﬁed on C18 columns and analysed in
20 runs of nanoscale liquid chromatography-tandem mass
spectrometry (LC-MS/MS) on a linear ion trap-Fourier Trans-
form mass spectrometer (LTQ-FT, Thermo Finnigan) using
data dependent acquisition as previously described (11).
RAW data ﬁles from the mass spectrometer were searched
against the Mascot database to identify peptides and map
them to proteins. The MSQuant open source software pack-
age (http://msquant.sourceforge.net/) was used for quantiﬁca-
tion of SILAC ratios for individual peptides.
Data analysis
A total 6311 unique peptides were identiﬁed and quantiﬁed
in the MS experiments. These were mapped to proteins and
protein ratios were calculated by averaging the individual
peptide ratios. To increase accuracy of the protein ratios we
demanded four or more quantiﬁed peptides for proteins to
be included in the analysis. If proteins were identiﬁed and
quantiﬁed with four or more peptides in more than one run
of the LC-MS/MS the mean of the protein ratios was used.
This resulted in a set of 504 proteins (unique Ensembl protein
IDs) that were identiﬁed and quantiﬁed (Supplementary
Table 1 online). The obtained protein ratios were log2
transformed and plotted in a histogram (Figure 1B). The dis-
tribution of log transformed protein ratios is skewed to the
left, but if the 20 most negative ratios are removed the result-
ing distribution is normal [Lilliefors (Kolmogorov–Smirnov)
normality test, n ¼ 484, P ¼ 0.1202]. Comparing to this dis-
tribution 12 proteins are repressed by miR-1 (P < 0.001, one-
sided parametric bootstrap test) (Supplementary Table 1
online).
The set of 504 identiﬁed and quantiﬁed proteins map to 496
unique Ensembl gene IDs (Supplementary Table 1 online).
These IDs were used for the comparisons in Figures 1C,
1D and 2B. The RNA ratios for miR-1 transfected HeLa
cells at 24 h (10) were downloaded from http://www.ncbi.
nlm.nih.gov/geo/ accession number: GSE2075. Out of the
496 Ensembl gene IDs identiﬁed in this study 398 could be
mapped to a corresponding mRNA ratio from the study by
Lim et al. (10). A total of 78 genes had failed the quality con-
trol of the DNA array and the remaining 20 genes could not
be identiﬁed on the array. For calculation of the overlap
between the miR-1 downregulated genes at the RNA and pro-
tein level 96 genes from the Supplementary Table 1 from Lim
et al. was used. Out of the 96 genes, 94 could be mapped to
an Ensembl gene ID and 7 of these were also identiﬁed in this
study. The P-value for the overlap between the miR-1 was
calculated with Fisher’s exact test for count data.
We also compared our data to miR-1 target predictions from
computational studies (6–8). TargetScanS predictions were
obtained from http://genes.mit.edu/tscan/targetscanS2005.
html, MiRanda predictions from http://www.microrna.org/
and PicTar predictions from http://pictar.bio.nyu.edu/cgi-bin/
new_PicTar_vertebrate.cgi. The signiﬁcance of the over-
laps with the different predictions were calculated with the
Fisher’s exact test for count data.
For analysis of miR-1 seedmatch (CAUUCC) occurrence
30-UTR sequences were obtained from the PACdb (12) data-
base and coding sequences were obtained from BioMart
(http://www.ensembl.org/Multi/martview). The occurrence
of the miR-1 seedmatch (CATTCC) per kb was calculated
for the 12 miR-1 downregulated genes, the remaining
484 genes identiﬁed in our study and for the entire database.
P-values were calculated by comparing the observed miR-1
seedmatch per kb value with a distribution of miR-1 seed-
match per kb values obtained by repeated sampling of
12 sequences from the set of 496 identiﬁed genes (Supple-
mentary Figure 1).
Luciferase assays
The HSV TK promoter was PCR ampliﬁed (Advantage PCR
Kit, Clontech) from pRL-TK (Promega) with the following
primers: 50-ATCGAGGTACCAAATGAGTCTTCGGACC-
TCGC-30 and 50-AGAAGAATCAAGCTTTTAAGCGG-30.
The PCR fragment was digested with KpnI and HindIII and
cloned into a KpnI/HindIII digested pGL4.12[luc2CP] vector
(Promega) to give pGL4.12-TK. A multiple cloning linker:
50-CTAGAGATCTGAATTCGGTACCACGCGTCTGCAG-
CTCGAGT-30 and 50-CTAGACTCGAGCTGCAGACGCG-
TGGTACCGAATTCAGATCT-30 was inserted into the
XbaI site of pGL4.12-TK to give pGL4.12-TK+. For the 16
genes found to be repressed by miR-1 the 30-UTR sequences
(Supplementary Table 2 online) were ampliﬁed from HeLa
genomic DNA using a primary and a nested PCR (Advantage
PCR Kit, Clontech) with two gene speciﬁc primersets
(Supplementary Table 2 online). The second primerset
included BglII and XhoI restriction sites (HAND2, ACTR3,
XRCC6, HNRPU, VARS2, DHX15, CAP1 and TPM3),
BamHI and XhoI restriction sites (ADAR and XRCC5) and
BglII and SalI (G6PD and CALR) for directional cloning into
pGL4.12-TK+. For 11 out of the 12 genes a nested PCR pro-
duct was obtained and TOPO cloned into pCR4-TOPO (Invi-
trogen) and subsequently subcloned into pGL4.12-TK+ using
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from Hand2 was cloned as a positive control (13). All
30-UTR sequences were veriﬁed by sequencing. For the luci-
ferase assays, 80000 HeLa cells/well in 12 well plates were
cotransfected with 0.9 mg pGL4.12-TK+ 30-UTR constructs,
0.1 mg pRL-TK (Promega) and 50 pmol miR-1 duplex
(50-UGGAAUGUAAAGAAGUAUGUAA-30,5 0-ACAUAC-
UUCUUUACAUUCAAUA-30) or miR-1 shufﬂed control
duplex (50-UUGUAUAGAAUAGAUGAGGAU-30,5 0-CCU-
CAUCUAUUCUAUACAAUU-30) (Ambion, annealed and
HPCL puriﬁed custom siRNA) per well. Transfections were
carried out with 3 ml of Lipofectamine 2000 (Invitrogen)
per well according to the recommendations of the manufac-
turer. The empty pGL4.12-TK+ vector was used as control.
Twenty-twohoursafterthetransfection,ﬁreﬂyandrenillaluci-
ferase activities were measured with the Dual-luciferase kit
(Promega) on a Turner Biosystems 20/20n Luminometer
using the DLR-2-INJ Promega protocol according to the
recommendations of the manufacturer. Transfections were
carried out in 10 replications and the error bars indicate
Figure 1. Identification of miR-1 targets with quantitative MS. (A) Schematic representation of the experimental set-up and the SILAC method. (B) Histogram of
the 504 log2 transformed protein ratios determined in this study. The distribution is skewed to the left, but if the 20 most negative ratios are removed the resulting
distribution (colored in red) is normal (Lilliefors ‘Kolmogorov–Smirnov’ normality test, n ¼ 484, P ¼ 0.1202). Comparing to this distribution 12 proteins
(colored in blue) are repressed by miR-1 (P < 0.001, one-sided parametric bootstrap test) (Supplementary Table 1 online). (C) 398 of the protein ratios obtained
in this study plotted against corresponding mRNA ratios (10) obtained 24 h after miR-1 transfection. (D) Venn diagram of genes regulated on the mRNA level
by miR-1 after 12 and 24 h (10) and the miR-1 repressed set of proteins identified in this study. P-value for the overlap is calculated with Fisher’s exact test for
count data.
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luciferase activity was normalized to the renilla luciferase
activity.Foreachconstructthevaluesarenormalizedtocontrol
miR transfection and a P-value was calculated with the
Student’s t-test (n ¼ 18) by comparing to the ratio between
the miR-1 and miR-control transfections to the same ratio for
the empty vector. Standard deviations for the ratios were
calculated using standard error propagation.
RESULTS
To investigate the regulatory effect of miRNA on the
proteome, we have used stable isotope labeling by amino
acids in cell culture (SILAC) (14). This method allows
quantitation of the relative protein abundance between two
cell populations (Figure 1A). In this study we compared
control-transfected HeLa cells with SILAC labeled HeLa
cells transfected with the muscle speciﬁc miR-1. Cells from
the two cell pools were mixed in a 1:1 ratio and nuclear
and cytoplasmic lysates were prepared. The two lysates were
size fractionated on a regular SDS-gel into 2 · 10 fractions,
in-gel digested with trypsin and the resulting peptide mixtures
were analysed in 20 runs of nanoscale LC-MS/MS on an ion
trap-Fourier Transform Mass Spectrometer, capable of very
high mass accuracy and of sequencing several peptides per
second (11). A total of 6311 unique peptide sequences were
matched to human genes with an average mass accuracy of
1 p.p.m. For each protein the corresponding peptide ratios
were averaged to give a representative protein ratio. To
increase accuracy of the measured ratios, we only included
the 504 proteins that had at least four unique quantiﬁed pep-
tides in our analysis, which also effectively removes any risk
of misidentiﬁcation of the proteins (Supplementary Table 1
online). These 504 proteins map to 496 unique Ensembl
gene IDs. The distribution of log2 transformed protein ratios
(Figure 1B) is skewed to the left as would be expected if
some proteins were present at a lower levels in the miR-1
transfected than the control transfected cells. A set of 12
proteins have protein ratios that are signiﬁcantly smaller
than the remaining protein ratios, which demonstrates that
the level of these proteins have been repressed by miR-1
transfection.
We were able to map 398 of our 496 identiﬁed genes to
the mRNA data obtained 24 h after miR-1 transfection (10)
Figure 2. miR-1 complementary sites in 30-UTR of repressed genes (A) The occurrence of the miR-1 seedmatch (CATTCC) per kb of 30-UTR and coding
sequence was calculated for the 12 miR-1 regulated genes, the remaining identified genes and for the entire 30-UTR and coding sequence databases
(Supplementary Table 1 online). P-values were calculated using a parametric bootstrap test comparing the observed value to a distribution of values obtained by
repeated calculation miR-1 seedmatches per kb for 12 of 30-UTRs or coding sequences randomly chosen from the set of identified genes (see Supplementary
Figure 1). (B) Overlap between our data and the combined computational predictions of miR-1 targets (Supplementary Table 1 online). The P-value for the
overlap was calculated with Fisher’s exact test for count data. (C) Relative luciferase activities for reporter constructs containing the indicated 30-UTR sequences
(Supplementary Table 2 online). Error bars indicate the SD (n ¼ 10). For each transfection firefly luciferase activity was normalized to renilla luciferase activity.
For each construct the values are normalized to control miR transfection. P-values was calculated by comparing the ratio between the miR-1 and miR-control
transfections to the same ratio for the empty vector with the Student’s t-test (n ¼ 18) and correcting for multiple testing with the Bonferroni correction.
Standard deviations for the ratios were calculated using standard error propagation. P-values <0.05 are indicated. Data and calculations are included in
Supplementary Table 2 online.
e107 Nucleic Acids Research, 2006, Vol. 34, No. 16 PAGE 4 OF 6(Figure 1C). The remaining 98 genes (including one from our
repressed set) either could not be identiﬁed on the array or
had failed the array quality control (see Supplementary
Table 1 online). For ﬁve of the proteins in our regulated set
we ﬁnd a clear correlation with the effects observed on the
mRNA level, but for the remaining six there is no correlation
(Figure 1C). Lim et al. (10) identify a set of 96 miR-1 targets
that are down regulated both at 12 and 24 h. We have protein
data for 7 of these 96 genes and ﬁnd that 4 are repressed on
the protein level as well as the RNA level. The overlap
between the two dataset is much larger than what would be
expected by chance (Figure 1D), indicating that the repres-
sion observed on the protein and RNA levels are related.
Generally miRNA target sites are found in the 30-UTRs of
genes. We ﬁnd that the 30-UTRs from 8 out of the 12 genes in
our miR-1 repressed set contain miR-1 seed sequences, which
is a signiﬁcant enrichment for miR-1 seedmatches compared
to the non-regulated set and the full 30-UTR data sequences
(12) (Figure 2A). This indicates that the repression we
observe is mediated via the 30-UTR. Moreover, we ﬁnd a
highly signiﬁcant overlap with the combined MiRanda (6),
PicTar (7) and TScanS (8) miR-1 target predictions, showing
that many of the miR-1 target that are detected by the SILAC
method also are predicted by computational methods
(Figure 2B). The overlap with individual prediction methods
is also highly signiﬁcant (see Supplementary Table 1 and
Supplementary Figure 2 online). To experimentally verify
that miR-1 regulation occurred via the 30-UTRs, we tested
the 30-UTRs from 11 of our regulated proteins in a reporter
system. As a positive control we used the 30-UTR from
Hand2, which has previously been shown to be a miR-1 tar-
get (13). Compared to the empty vector 6 out of the 11 UTRs
were found to repress expression in an miR-1 dependent
fashion (Figure 2C).
DISCUSSION
In this study we have transfected miR-1 into HeLa cells to
investigate the effect of miRNAs on protein levels. Of the
504 identiﬁed and quantiﬁed proteins 12 (2.4%) were found
to be signiﬁcantly repressed by miR-1 (Supplementary
Table 1 online). In comparison, 96 out of  22000 mRNAs
(0.44%) were found to be repressed by miR-1 using DNA
microarrays (10). Our ﬁndings therefore suggest that single
highly expressed miRNA, such as miR-1, can regulate a
substantial percentage of the proteome and have a profound
effect on expression in that tissue.
In human cells miRNAs are believed to predominantly
affect the translation of target mRNAs (1), although regula-
tion of mRNA levels has also been reported (10). We ﬁnd
a signiﬁcant overlap between the genes repressed by miR-1
on the mRNA and protein levels. For some genes repression
is observed both at the mRNA and the protein level, while
others are regulated only on the protein or the RNA level
(Figure 1C). Recently, it has been suggested that miRNAs
decrease mRNA levels by relocalization of translational
repressed mRNAs to P-bodies and increasing decapping (5).
It is possible that some mRNAs are more prone to decapping
and degradation in P-bodies than others, which would explain
the partial overlap between the effects observed on the
mRNA (10) and protein level. However, some miR-1 target
genes may have a very long mRNA or protein half-life
and this could also be an explanation for our ﬁndings. In
all cases our results suggests that the regulation occurring
on the mRNA and protein levels are related.
It is now well documented that most siRNAs will have off-
target effects that are dependent on the seed region and can
detected at the RNA level (10,15,16). Our ﬁndings suggest
that some siRNA off-target effects could be present only at
the protein level and therefore further emphasize that results
from siRNA experiments should be interpreted with caution
and proper controls should be performed.
In vivo, miR-1 is expressed at very high levels (more than
100000 copies per cell) in skeletal muscle and heart tissue,
but only at very low levels in other tissues (10). Several of
the proteins that we identify as miR-1 targets have muscle
related functions and could potentially be important miR-1
targets in vivo. ACTR3 (ARP3 actin-related protein 3 homo-
log) is part of the Arp2/3 complex, which is involved
in nucleating the formation of actin ﬁlaments (17). TPM3
(tropomyosin 3) is a component of the sarcomere’s thin
ﬁlaments and is involved in calcium mediated regulation of
the myosin–actin interaction (18). CALR (calreticulin) is a
calcium-binding protein localized to the lumen of the endo-
plasmic and sarcoplasmic reticulum that may be involved
in calcium storage (19).
For 6 out 11 miR-1 target genes identiﬁed in our SILAC
experiment, we demonstrate that the miR-1 mediated repres-
sion occurs via the 30-UTR. For the remaining ﬁve we see
little or no effect of the 30-UTR in our reporter experiments.
It is possible that these genes are regulated in vivo via miR-1
complementary sites in the coding sequence or that the 30-
UTRs were incorrectly annotated. One example of this is
probably ACTR3. For the reporter experiments we have
used the 1135 bases long ACTR3 30-UTR sequence from
the NCBI refseq mRNA that does not have any miR-1 com-
plementary sites. However, the 30-UTR annotated in the
PACdb 30-UTR database (12) is considerable longer and con-
tains two miR-1 seed sequences. Obviously, it is also possible
that some of the miR-1 target genes that we identify are
repressed by miR-1 indirectly as a result of secondary effects.
XRCC5 (Ku autoantigen, 80 kDa) and XRCC6 (Ku autoanti-
gen, 70 kDa) make up the regulatory subunit of the nuclear
serine/threonine protein kinase DNA-PK that is crucial for
repair of double stranded DNA breaks. Interestingly, we
ﬁnd that the nuclear and cytoplasmic protein levels of both
these proteins are repressed by miR-1 transfection. However,
the 30-UTR from the mRNAs encoding these two proteins
does not have any recognizable miR-1 complementary sites
and do not inhibit expression in our reporter experiment, indi-
cating that the regulation of XRCC5 and XRCC6 may be
secondary to some miR-1 or transfection induced regulation
of the DNA-PK protein complex.
In our experiments we have tested the effect of transfection
of the muscle speciﬁc miR-1 into HeLa cells that are derived
from the cervix. It is possible that some of the miR-1 target
genes that we and Lim et al. (10) identify are physiologically
irrelevant in the sense that they may be expressed in HeLa,
but not together with miR-1 in vivo. The 30-UTR of mRNAs
that are not expressed in muscle cells has a tendency to con-
tain nonconserved miR-1 target sites and many of these are
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such physiologically irrelevant miR target genes it could be
advantageous to use miRNA inhibition rather than miRNA
transfection for future miRNA target genes identiﬁcation
experiments.
The capacity of the quantitative MS/MS method for
miRNA target gene identiﬁcation that we present here
could be further improved by more extensive fractionation
of proteins before MS analysis. Also addition of an afﬁnity
puriﬁcation step could be combined with our method to
allow for detection of speciﬁc classes of proteins and less
abundant proteins, such as transcription factors. Compared
to strategies based on DNA microarray detection of
mRNAs, proteomic strategies to miRNA target detection
will remain low through-put. Nevertheless, we believe that
methods such as ours could complement DNA microarray
experiments. First, all methods for detection of miRNA target
genes are susceptible to detection of indirect targets that
are repressed through secondary effects. It is therefore neces-
sary to use short time frames for the experiments. For some
genes the half life of the protein may be much shorter than
the mRNA allowing for detection of miRNA mediated
repression only at the protein level. Second, the exact
mechanism of miRNA mediated repression is still debated
and it is not known how miRNA mediated mRNA destabili-
zation and translational repression relate to each other. DNA
microarray experiments only detect a fraction of the potential
miRNA targets that can be predicted in silico (10,15,16). Our
results indicate that some genes may be repressed on the
protein level without being affected on the mRNA level
and for such miRNA target genes a proteomic strategy will
be necessary for detection.
In conclusion, we demonstrate that many proteins can be
directly repressed by a single highly expressed miRNA and
that SILAC can be used for miRNA target identiﬁcation.
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